237 related articles for article (PubMed ID: 6395814)
21. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
22. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
Doberstyn EB; Phintuyothin P; Noeypatimanondh S; Teerakiartkamjorn C
Bull World Health Organ; 1979; 57(2):275-9. PubMed ID: 373903
[TBL] [Abstract][Full Text] [Related]
23. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
Lell B; Lehman LG; Schmidt-Ott JR; Sturchler D; Handschin J; Kremsner PG
Am J Trop Med Hyg; 1998 May; 58(5):619-24. PubMed ID: 9598451
[TBL] [Abstract][Full Text] [Related]
24. The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490).
Peters W; Howells RE; Portus J; Robinson BL; Thomas S; Warhurst DC
Ann Trop Med Parasitol; 1977 Dec; 71(4):407-18. PubMed ID: 339856
[TBL] [Abstract][Full Text] [Related]
25. [Combined action of pyronaridine and sulfadoxine/pyrimethamine against Plasmodium berghei ANKA strain in mice].
Shi XH; Shao BR; Ye XY
Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):66-9. PubMed ID: 2206014
[TBL] [Abstract][Full Text] [Related]
26. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
[TBL] [Abstract][Full Text] [Related]
28. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
30. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
[TBL] [Abstract][Full Text] [Related]
31. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
[TBL] [Abstract][Full Text] [Related]
32. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
[TBL] [Abstract][Full Text] [Related]
33. Open comparison of mefloquine, mefloquine/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children.
Sowunmi A; Oduola AM
Trans R Soc Trop Med Hyg; 1995; 89(3):303-5. PubMed ID: 7660443
[TBL] [Abstract][Full Text] [Related]
34. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
35. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
36. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
Brockelman CR; Thanomsub B; Bhisutthibhand J
Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
[TBL] [Abstract][Full Text] [Related]
37. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.
Nosten F; Imvithaya S; Vincenti M; Delmas G; Lebihan G; Hausler B; White N
Bull World Health Organ; 1987; 65(6):891-6. PubMed ID: 3325187
[TBL] [Abstract][Full Text] [Related]
38. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Arnold K
Lancet; 1985 Mar; 1(8430):704. PubMed ID: 2858655
[No Abstract] [Full Text] [Related]
39. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate?
Peters W
Ann Trop Med Parasitol; 1999 Sep; 93(6):569-87. PubMed ID: 10707103
[TBL] [Abstract][Full Text] [Related]
40. A phase II clinical trial of mefloquine in Brazilian male subjects.
de Souza JM
Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
